Clinical trial
SU5416, Irinotecan, and Cisplatin in Treating Patients With Advanced Solid…
NCT00006000 · Ohio State University Comprehensive Cancer Center, Other · Completed
Key facts
| NCT number | NCT00006000 |
|---|---|
| Title | SU5416, Irinotecan, and Cisplatin in Treating Patients With Advanced Solid Tumors |
| Official title | Phase I Study of SU5416 in Combination With CPT-11 and Cisplatin in Patients With Solid Tumors |
| Lead sponsor | Ohio State University Comprehensive Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Unspecified Adult Solid Tumor, Protocol Specific |
| Intervention type | Drug |
| Interventions | cisplatin, irinotecan hydrochloride, semaxanib |
| Start date | Aug 1, 2000 |
| Completion | Mar 1, 2004 |
| First posted | Mar 5, 2004 |
| Last update posted | Jan 31, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: